Product Images Blenrep

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 4 images provide visual information about the product associated with Blenrep NDC 0173-0913 by Glaxosmithkline Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Belantamab mafodotin-blmf chemical structure - blenrep spl graphic 01

Belantamab mafodotin-blmf chemical structure - blenrep spl graphic 01

Not available.*

Figure 1 - blenrep spl graphic 02

Figure 1 - blenrep spl graphic 02

Figure 2 - blenrep spl graphic 03

Figure 2 - blenrep spl graphic 03

Blenrep 70 mg per vial carton - blenrep spl graphic 04

Blenrep 70 mg per vial carton - blenrep spl graphic 04

This text provides information about a medication called BLENREP (belantamab mafodotin-blmf) for injection, which is administered through intravenous infusion after reconstitution and dilution. It is important to note that this drug is hazardous and contains no preservative. Each package includes a single-dose vial, and any unused portion should be discarded. Additionally, it is necessary to dispense the enclosed Medication Guide to each patient. The National Drug Code (NDC) for this medication is 0173-0913-01.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.